Tatva Chintan Pharma Chem Ltd vs Vinati Organics Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Tatva Chintan Pharma Chem Ltd is ₹ 1127 as of 20 Mar 15:30 . The P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 53.4 on March 2022 to 278.3 on March 2025 . This represents a CAGR of 51.09% over 4 yearsThe P/E Ratio of Vinati Organics Ltd changed from 53.4 on March 2021 to 40.4 on March 2025 . This represents a CAGR of -5.43% over 5 years The Market Cap of Tatva Chintan Pharma Chem Ltd changed from ₹ 5115 crore on March 2022 to ₹ 1588 crore on March 2025 . This represents a CAGR of -25.35% over 4 yearsThe Market Cap of Vinati Organics Ltd changed from ₹ 14388 crore on March 2021 to ₹ 16377 crore on March 2025 . This represents a CAGR of 2.62% over 5 years The revenue of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 133.07 crore as compare to the Sep '25 revenue of ₹ 124.52 crore. This represent the growth of 6.87% The revenue of Vinati Organics Ltd for the Dec '25 is ₹ 539.64 crore as compare to the Sep '25 revenue of ₹ 566.23 crore. This represent the decline of -4.7% The ebitda of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 27.22 crore as compare to the Sep '25 ebitda of ₹ 23.22 crore. This represent the growth of 17.23% The ebitda of Vinati Organics Ltd for the Dec '25 is ₹ 165.42 crore as compare to the Sep '25 ebitda of ₹ 183.34 crore. This represent the decline of -9.77% The net profit of Tatva Chintan Pharma Chem Ltd changed from ₹ 5.21 crore to ₹ 15.17 crore over 7 quarters. This represents a CAGR of 84.17% The net profit of Vinati Organics Ltd changed from ₹ 84.15 crore to ₹ 100.83 crore over 7 quarters. This represents a CAGR of 10.89% The Dividend Payout of Tatva Chintan Pharma Chem Ltd changed from 19.56 % on March 2021 to 708.79 % on March 2025 . This represents a CAGR of 105.04% over 5 yearsThe Dividend Payout of Vinati Organics Ltd changed from 22.9 % on March 2021 to 18.73 % on March 2025 . This represents a CAGR of -3.94% over 5 years .

About Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
The status of the Company converted from Private Limited into a Public Limited Company from 27 January 2021 and the name of Company changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).

About Vinati Organics Ltd

Incorporated in June, 1989, Vinati Organics Limited is engaged in manufacturing of speciality organic intermediates and monomers and polymers.
Its manufacturing facilities are located at Mahad and Lote Parashuram, Maharashtra.
Company is the world's largest manufacturer of Isobutyl Benzene (IBB) and 2-Acrylamido 2 Methylpropane Sulfonic Acid (ATBS) and India's largest manufacturer IsoButylene (IB) and Butyl Phenols, the prime raw material for the manufacture of ibuprofen, a vital bulk drug. Vinati Organics came out with a public issue in Nov.'91 to set up a plant to manufacture 1200 tpa of iso butyl benzene, in Mahad (Raigad district), Maharashtra.
Commercial production commenced in Jul.'92. The company has a technical collaboration with Institut Francais du Petrole (IFP), France, one of the largest licensors in the field of petroleum refining and petrochemical processes and catalysts.

FAQs for the comparison of Tatva Chintan Pharma Chem Ltd and Vinati Organics Ltd

Which company has a larger market capitalization, Tatva Chintan Pharma Chem Ltd or Vinati Organics Ltd?

Market cap of Tatva Chintan Pharma Chem Ltd is 2,637 Cr while Market cap of Vinati Organics Ltd is 14,374 Cr

What are the key factors driving the stock performance of Tatva Chintan Pharma Chem Ltd and Vinati Organics Ltd?

The stock performance of Tatva Chintan Pharma Chem Ltd and Vinati Organics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Tatva Chintan Pharma Chem Ltd and Vinati Organics Ltd?

As of March 23, 2026, the Tatva Chintan Pharma Chem Ltd stock price is INR ₹1127.45. On the other hand, Vinati Organics Ltd stock price is INR ₹1386.65.

How do dividend payouts of Tatva Chintan Pharma Chem Ltd and Vinati Organics Ltd compare?

To compare the dividend payouts of Tatva Chintan Pharma Chem Ltd and Vinati Organics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.